GRCE GRACE THERAPEUTICS INC Product Launches 8-K Filing 2024 - Trial Enrollment Complete ACASTI PHARMA INC announced that its pivotal Phase 3 STRIVE-ON safety trial has completed enrollment as of September 25, 2024.Get access to all SEC 8-K filings of the GRACE THERAPEUTICS INC